How Pharma Manages Organisational Complexity (MedNous)
Big Pharma companies deliver value and innovation to patients through the scale and diversity of their portfolios. However, as scale and diversity increase, so too does organisational complexity. To effectively manage increasing complexity, organisations need to define a clear strategic focus and embed a fit-for-purpose operating model. This article, published in MedNous, analyses six companies […]
Approaches to Managing Organisational Complexity
Big Pharma companies deliver value and innovation to patients through the scale and diversity of their portfolios. However, as scale and diversity increase, so too does organisational complexity. To effectively manage increasing complexity, organisations need to define a clear strategic focus and embed a fit-for-purpose operating model. There is no single approach to doing this, […]
Managing Organisational Complexity in Big Pharma
Organisational complexity and scale are two sides of the same coin. In a quest for scale, Big Pharma companies have built large, diverse portfolios that span multiple therapeutic areas and technologies. But this comes with its own set of challenges. Portfolio diversity leads to inevitable organisational complexity, requiring leaders to think more proactively about decision-making […]
The Art of Effective R&D Transformation
An effective pharmaceutical R&D transformation shapes the R&D function into a high-performing one. Such transformations cover many aspects and affect many people, so require clarity, simplicity, and sustained effort to have an impact. The reason that companies engage in R&D transformation is usually a concern about R&D productivity. High attrition rates and regulations that increase […]
Transform Value And Access
A complex and evolving pharmaceutical ecosystem driven by rapidly changing healthcare policies, increasing payer sophistication, and greater patient needs, makes a challenging environment in which to secure favourable patient access to medicines. Patient access will be at the top of the leadership agenda for pharmaceutical companies. To deliver it will require the transformation of Value […]
Reimagine Medical Affairs
Building successful medical affairs teams A successful medical affairs team bridges clinical development and commercial functions to drive the uptake of innovative medicines. It includes clinicians who understand the clinical context, and the barriers and opportunities to getting innovative medicines to patients. It balances a team of experienced people with access to external competencies to […]
Pharmaceutical Leadership: Requirements for Success
Leading pharmaceutical companies have one common denominator: they possess leaders who provide their organisation with a clear strategic focus to successfully deliver on their priorities. These leaders have the capacity to make bold decisions, navigate new challenges, and empower their teams to drive the organisation towards its goals. In this white paper, we take a […]
How R&D Teams Create Value from On-Market Products (MedNous)
Most pharma R&D organisations are defined and measured by how well they deliver new product innovation, which is often a high risk, high return endeavour. Yet such companies almost always have a second, highly important and sometimes underappreciated role: creating value from on market products. This article, published in MedNous, analyses the performance of these […]
How R&D Teams Create Value from On-Market Products
Most pharma R&D organisations are defined and measured by how well they deliver new product innovation, which is often a high risk, high return endeavour. Yet such companies almost always have a second, highly important and sometimes underappreciated role: creating value from on-market products. Some companies even avoid new product innovation entirely, but still have […]
How to Power Pharma and Biotech R&D with Sharp Commercial Insights
Pharmaceutical research and development (R&D) organisations and pre-revenue biotechs aim to discover and develop medicines that will make a meaningful difference to patients’ lives. Such medicines will be those that are ‘commercially’ successful, so ‘commercial insight’ is a must-have for any effective R&D effort. In this article we explore how pharma and biotech companies leverage […]